HDFC Charity Fund for Cancer Cure-Direct Plan-(75% IDCW Donation Option)
Ticker: mf17019
Risky
48/100
☆ Add to Watchlist
More Options
H
HDFC Charity Fund for Cancer Cure-Direct Plan-(50% IDCW Donation Option)
The fund has a decent score, indicating a socially responsible investment with moderate growth potential but some risks in execution and cash flow management.
View details
I
Invesco India Gold ETF FoF(IDCW)
Invesco India Gold ETF FoF presents a decent investment opportunity, primarily driven by the stability of gold as an asset class. However, investors should be cautious of market volatility and external economic factors.
View details
B
Baroda BNP Paribas Credit Risk Fund(Q-IDCW)
The fund shows several weaknesses in growth consistency and market sentiment, making it a risky investment.
View details
B
Baroda BNP Paribas Credit Risk Fund(M-IDCW)
The fund presents a risky investment opportunity with limited growth potential and concerns regarding profitability and governance.
View details
B
Bandhan Nifty 100 Index Fund(IDCW Reinvest)
The Bandhan Nifty 100 Index Fund presents a decent investment opportunity with a balanced risk-reward profile, but investors should remain cautious of execution risks.
View details
B
Bandhan Nifty 100 Index Fund(IDCW)
The Bandhan Nifty 100 Index Fund shows decent potential with a diversified portfolio and consistent growth metrics, though some risks and governance concerns exist.
View details
K
Kotak Nifty SDL Jul 2033 Index Fund(IDCW)
The Kotak Nifty SDL Jul 2033 Index Fund presents a decent investment opportunity with stable returns, though it lacks the growth potential of equities.
View details
D
DSP FMP 270-1144D(IDCW)
The stock shows decent fundamentals but lacks strong growth prospects and has some liquidity concerns.
View details
E
Edelweiss Nifty 50 Index Fund(IDCW)
The Edelweiss Nifty 50 Index Fund shows decent potential for investors looking for exposure to the Nifty 50, but caution is advised due to market volatility and average profitability metrics.
View details
U
UTI FTIF-XXXV-II(1223D)(A-IDCW)
The stock shows moderate potential but is hindered by inconsistent growth and valuation concerns.
View details
U
UTI FTIF-XXXV-II(1223D)(F-IDCW)
The stock presents a mixed outlook with moderate growth potential but faces challenges in profitability and valuation metrics.
View details
U
UTI FTIF-XXXV-II(1223D)(Q-IDCW)
The stock shows potential but carries moderate risks that need to be monitored closely.
View details
U
UTI FTIF-XXXV-II(1223D)(IDCW)
The stock shows potential but carries risks that need to be monitored closely.
View details
H
Helios Financial Services Fund(IDCW)
While Helios Financial Services Fund shows some potential, the inconsistencies in growth and profitability, along with valuation concerns, suggest a cautious approach is warranted.
View details
H
Helios Financial Services Fund(IDCW Payout)
The Helios Financial Services Fund shows several weaknesses in growth, profitability, and valuation, making it a risky investment at this time.
View details
L
LIC MF Value Fund(IDCW)
The LIC MF Value Fund shows potential but faces challenges in growth consistency and valuation. Investors should be cautious.
View details
Business Overview
The HDFC Charity Fund for Cancer Cure - Direct Plan is a unique investment option that combines financial growth with social responsibility. Designed for socially conscious investors, this fund allocates 75% of its income distribution to support cancer care initiatives. It matters because it empowers individuals to contribute to a noble cause while potentially earning returns. By choosing this fund, investors can make a meaningful impact in the fight against cancer.
- Supports cancer care initiatives
- 75% IDCW goes to charity
- Ideal for socially conscious investors
- Combines financial growth with philanthropy
- Promotes community health and well-being
Investment Thesis
HDFC Charity Fund for Cancer Cure stands out due to its strong promoter credibility, significant growth in digital services, and attractive valuation compared to peers. This fund not only contributes to a noble cause but also offers a promising investment opportunity for socially conscious investors.
- Backed by HDFC's robust reputation and credibility in the financial sector.
- Digital services are expanding rapidly, enhancing accessibility and investor engagement.
- Valuation metrics indicate potential for strong returns compared to industry peers.
- Aligns with socially responsible investing, appealing to conscious investors.
- Offers a unique blend of philanthropy and financial growth potential.
Opportunity vs Risk
Opportunities
- Strong brand reputation
- Growing healthcare sector
- Tax benefits on donations
- Potential for high returns
- Support for cancer research
Risks ⚠️
- Market volatility
- Regulatory changes
- Limited liquidity
- Dependence on donations
- Economic downturn impact
Peer Perspective
HDFC Charity Fund for Cancer Cure trades at a premium compared to peers like SBI Mutual Fund and ICICI Prudential, driven by its strong donation focus; a sustained increase in donor engagement could trigger a rerating.
📊 Stock Investment Checklist (100 Points)
HDFC Charity Fund for Cancer Cure-Direct Plan-(75% IDCW Donation Option) • Updated: 2025-10-01 06:01:57
-
10BusinessHighThe sector is focused on healthcare, which is future-ready, but the business model lacks a clear competitive moat.
-
8GrowthHighRevenue growth has been inconsistent, with fluctuating profit margins.
-
6ProfitabilityGoodROE and ROCE are below industry averages, and cash flow is not consistently strong.
-
7ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
5BalanceGoodThe balance sheet shows moderate debt levels, but liquidity is adequate.
-
8GovernanceHighPromoter holding is strong, but there are some concerns regarding disclosures.
-
4DriversGoodLimited growth catalysts and execution risks are present.
-
0TechnicalsLowMarket sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
The fund faces significant challenges in growth and profitability, making it a risky investment.